Agriculture
Global Inactivated Porcine Parvovirus Vaccine Market Research Report 2025
- Mar 11, 25
- ID: 54015
- Pages: 99
- Figures: 103
- Views: 14
The global market for Inactivated Porcine Parvovirus Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The porcine parvovirus inactivated vaccine is used for preventing a porcine parvovirus disease caused by a porcine parvovirus.
North American market for Inactivated Porcine Parvovirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inactivated Porcine Parvovirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inactivated Porcine Parvovirus Vaccine include Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology, DHN, China Animal Husbandy Industry, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Parvovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Parvovirus Vaccine.
The Inactivated Porcine Parvovirus Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Porcine Parvovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Porcine Parvovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
HIPRA
Zoetis
Ceva
Bioveta
Boehringer Ingelheim
Harbin Pharmaceutical Group
Wuhan Keqian Biology
DHN
China Animal Husbandy Industry
Qilu Animal Health Products Factorys
Shandong HuaHong Biological Engineering
Shanghai Hile Biological
Liaoning Yikang Biological
Jilin Zhengye Biological Product
by Type
<107.0 TCID50/mL
≥107.0 TCID50/mL
by Application
Sows
Gilts
Boars
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Porcine Parvovirus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Inactivated Porcine Parvovirus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Inactivated Porcine Parvovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The porcine parvovirus inactivated vaccine is used for preventing a porcine parvovirus disease caused by a porcine parvovirus.
North American market for Inactivated Porcine Parvovirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inactivated Porcine Parvovirus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inactivated Porcine Parvovirus Vaccine include Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology, DHN, China Animal Husbandy Industry, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Parvovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Parvovirus Vaccine.
The Inactivated Porcine Parvovirus Vaccine market size, estimations, and forecasts are provided in terms of output/shipments (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Porcine Parvovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Porcine Parvovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
HIPRA
Zoetis
Ceva
Bioveta
Boehringer Ingelheim
Harbin Pharmaceutical Group
Wuhan Keqian Biology
DHN
China Animal Husbandy Industry
Qilu Animal Health Products Factorys
Shandong HuaHong Biological Engineering
Shanghai Hile Biological
Liaoning Yikang Biological
Jilin Zhengye Biological Product
by Type
<107.0 TCID50/mL
≥107.0 TCID50/mL
by Application
Sows
Gilts
Boars
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Porcine Parvovirus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Inactivated Porcine Parvovirus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Inactivated Porcine Parvovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 Inactivated Porcine Parvovirus Vaccine Market Overview
1.1 Product Definition
1.2 Inactivated Porcine Parvovirus Vaccine by Type
1.2.1 Global Inactivated Porcine Parvovirus Vaccine Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 <107.0 TCID50/mL
1.2.3 ≥107.0 TCID50/mL
1.3 Inactivated Porcine Parvovirus Vaccine by Application
1.3.1 Global Inactivated Porcine Parvovirus Vaccine Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Sows
1.3.3 Gilts
1.3.4 Boars
1.4 Global Market Growth Prospects
1.4.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Inactivated Porcine Parvovirus Vaccine Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Inactivated Porcine Parvovirus Vaccine Production Estimates and Forecasts (2020-2031)
1.4.4 Global Inactivated Porcine Parvovirus Vaccine Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Inactivated Porcine Parvovirus Vaccine, Industry Ranking, 2023 VS 2024
2.4 Global Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Date of Enter into This Industry
2.9 Inactivated Porcine Parvovirus Vaccine Market Competitive Situation and Trends
2.9.1 Inactivated Porcine Parvovirus Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Inactivated Porcine Parvovirus Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Inactivated Porcine Parvovirus Vaccine Production by Region
3.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Region (2020-2031)
3.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Inactivated Porcine Parvovirus Vaccine by Region (2026-2031)
3.3 Global Inactivated Porcine Parvovirus Vaccine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Inactivated Porcine Parvovirus Vaccine Production Volume by Region (2020-2031)
3.4.1 Global Inactivated Porcine Parvovirus Vaccine Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Inactivated Porcine Parvovirus Vaccine by Region (2026-2031)
3.5 Global Inactivated Porcine Parvovirus Vaccine Market Price Analysis by Region (2020-2025)
3.6 Global Inactivated Porcine Parvovirus Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
4 Inactivated Porcine Parvovirus Vaccine Consumption by Region
4.1 Global Inactivated Porcine Parvovirus Vaccine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2031)
4.2.1 Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2025)
4.2.2 Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2020-2031)
5.1.1 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2020-2025)
5.1.2 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2026-2031)
5.1.3 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2020-2031)
5.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2020-2031)
5.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2020-2025)
5.2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2026-2031)
5.2.3 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2020-2031)
5.3 Global Inactivated Porcine Parvovirus Vaccine Price by Type (2020-2031)
6 Segment by Application
6.1 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2020-2031)
6.1.1 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2020-2025)
6.1.2 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2026-2031)
6.1.3 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2020-2031)
6.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2020-2031)
6.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2020-2025)
6.2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2026-2031)
6.2.3 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2020-2031)
6.3 Global Inactivated Porcine Parvovirus Vaccine Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Merck Animal Health
7.1.1 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Company Information
7.1.2 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.1.3 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Merck Animal Health Main Business and Markets Served
7.1.5 Merck Animal Health Recent Developments/Updates
7.2 HIPRA
7.2.1 HIPRA Inactivated Porcine Parvovirus Vaccine Company Information
7.2.2 HIPRA Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.2.3 HIPRA Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.2.4 HIPRA Main Business and Markets Served
7.2.5 HIPRA Recent Developments/Updates
7.3 Zoetis
7.3.1 Zoetis Inactivated Porcine Parvovirus Vaccine Company Information
7.3.2 Zoetis Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.3.3 Zoetis Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Zoetis Main Business and Markets Served
7.3.5 Zoetis Recent Developments/Updates
7.4 Ceva
7.4.1 Ceva Inactivated Porcine Parvovirus Vaccine Company Information
7.4.2 Ceva Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.4.3 Ceva Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Ceva Main Business and Markets Served
7.4.5 Ceva Recent Developments/Updates
7.5 Bioveta
7.5.1 Bioveta Inactivated Porcine Parvovirus Vaccine Company Information
7.5.2 Bioveta Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.5.3 Bioveta Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Bioveta Main Business and Markets Served
7.5.5 Bioveta Recent Developments/Updates
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Company Information
7.6.2 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.6.3 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Boehringer Ingelheim Main Business and Markets Served
7.6.5 Boehringer Ingelheim Recent Developments/Updates
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Company Information
7.7.2 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.7.3 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Harbin Pharmaceutical Group Main Business and Markets Served
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.8 Wuhan Keqian Biology
7.8.1 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Company Information
7.8.2 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.8.3 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Wuhan Keqian Biology Main Business and Markets Served
7.8.5 Wuhan Keqian Biology Recent Developments/Updates
7.9 DHN
7.9.1 DHN Inactivated Porcine Parvovirus Vaccine Company Information
7.9.2 DHN Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.9.3 DHN Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.9.4 DHN Main Business and Markets Served
7.9.5 DHN Recent Developments/Updates
7.10 China Animal Husbandy Industry
7.10.1 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Company Information
7.10.2 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.10.3 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.10.4 China Animal Husbandy Industry Main Business and Markets Served
7.10.5 China Animal Husbandy Industry Recent Developments/Updates
7.11 Qilu Animal Health Products Factorys
7.11.1 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Company Information
7.11.2 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.11.3 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Qilu Animal Health Products Factorys Main Business and Markets Served
7.11.5 Qilu Animal Health Products Factorys Recent Developments/Updates
7.12 Shandong HuaHong Biological Engineering
7.12.1 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Company Information
7.12.2 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.12.3 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Shandong HuaHong Biological Engineering Main Business and Markets Served
7.12.5 Shandong HuaHong Biological Engineering Recent Developments/Updates
7.13 Shanghai Hile Biological
7.13.1 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Company Information
7.13.2 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.13.3 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Shanghai Hile Biological Main Business and Markets Served
7.13.5 Shanghai Hile Biological Recent Developments/Updates
7.14 Liaoning Yikang Biological
7.14.1 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Company Information
7.14.2 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.14.3 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Liaoning Yikang Biological Main Business and Markets Served
7.14.5 Liaoning Yikang Biological Recent Developments/Updates
7.15 Jilin Zhengye Biological Product
7.15.1 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Company Information
7.15.2 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.15.3 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Jilin Zhengye Biological Product Main Business and Markets Served
7.15.5 Jilin Zhengye Biological Product Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Inactivated Porcine Parvovirus Vaccine Industry Chain Analysis
8.2 Inactivated Porcine Parvovirus Vaccine Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Inactivated Porcine Parvovirus Vaccine Production Mode & Process Analysis
8.4 Inactivated Porcine Parvovirus Vaccine Sales and Marketing
8.4.1 Inactivated Porcine Parvovirus Vaccine Sales Channels
8.4.2 Inactivated Porcine Parvovirus Vaccine Distributors
8.5 Inactivated Porcine Parvovirus Vaccine Customer Analysis
9 Inactivated Porcine Parvovirus Vaccine Market Dynamics
9.1 Inactivated Porcine Parvovirus Vaccine Industry Trends
9.2 Inactivated Porcine Parvovirus Vaccine Market Drivers
9.3 Inactivated Porcine Parvovirus Vaccine Market Challenges
9.4 Inactivated Porcine Parvovirus Vaccine Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Inactivated Porcine Parvovirus Vaccine by Type
1.2.1 Global Inactivated Porcine Parvovirus Vaccine Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 <107.0 TCID50/mL
1.2.3 ≥107.0 TCID50/mL
1.3 Inactivated Porcine Parvovirus Vaccine by Application
1.3.1 Global Inactivated Porcine Parvovirus Vaccine Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Sows
1.3.3 Gilts
1.3.4 Boars
1.4 Global Market Growth Prospects
1.4.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Inactivated Porcine Parvovirus Vaccine Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Inactivated Porcine Parvovirus Vaccine Production Estimates and Forecasts (2020-2031)
1.4.4 Global Inactivated Porcine Parvovirus Vaccine Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Inactivated Porcine Parvovirus Vaccine, Industry Ranking, 2023 VS 2024
2.4 Global Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Product Offered and Application
2.8 Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Date of Enter into This Industry
2.9 Inactivated Porcine Parvovirus Vaccine Market Competitive Situation and Trends
2.9.1 Inactivated Porcine Parvovirus Vaccine Market Concentration Rate
2.9.2 Global 5 and 10 Largest Inactivated Porcine Parvovirus Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Inactivated Porcine Parvovirus Vaccine Production by Region
3.1 Global Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Region (2020-2031)
3.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Inactivated Porcine Parvovirus Vaccine by Region (2026-2031)
3.3 Global Inactivated Porcine Parvovirus Vaccine Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Inactivated Porcine Parvovirus Vaccine Production Volume by Region (2020-2031)
3.4.1 Global Inactivated Porcine Parvovirus Vaccine Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Inactivated Porcine Parvovirus Vaccine by Region (2026-2031)
3.5 Global Inactivated Porcine Parvovirus Vaccine Market Price Analysis by Region (2020-2025)
3.6 Global Inactivated Porcine Parvovirus Vaccine Production and Value, Year-over-Year Growth
3.6.1 North America Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Inactivated Porcine Parvovirus Vaccine Production Value Estimates and Forecasts (2020-2031)
4 Inactivated Porcine Parvovirus Vaccine Consumption by Region
4.1 Global Inactivated Porcine Parvovirus Vaccine Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2031)
4.2.1 Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2025)
4.2.2 Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2020-2031)
5.1.1 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2020-2025)
5.1.2 Global Inactivated Porcine Parvovirus Vaccine Production by Type (2026-2031)
5.1.3 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2020-2031)
5.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2020-2031)
5.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2020-2025)
5.2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Type (2026-2031)
5.2.3 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2020-2031)
5.3 Global Inactivated Porcine Parvovirus Vaccine Price by Type (2020-2031)
6 Segment by Application
6.1 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2020-2031)
6.1.1 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2020-2025)
6.1.2 Global Inactivated Porcine Parvovirus Vaccine Production by Application (2026-2031)
6.1.3 Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2020-2031)
6.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2020-2031)
6.2.1 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2020-2025)
6.2.2 Global Inactivated Porcine Parvovirus Vaccine Production Value by Application (2026-2031)
6.2.3 Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2020-2031)
6.3 Global Inactivated Porcine Parvovirus Vaccine Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Merck Animal Health
7.1.1 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Company Information
7.1.2 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.1.3 Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Merck Animal Health Main Business and Markets Served
7.1.5 Merck Animal Health Recent Developments/Updates
7.2 HIPRA
7.2.1 HIPRA Inactivated Porcine Parvovirus Vaccine Company Information
7.2.2 HIPRA Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.2.3 HIPRA Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.2.4 HIPRA Main Business and Markets Served
7.2.5 HIPRA Recent Developments/Updates
7.3 Zoetis
7.3.1 Zoetis Inactivated Porcine Parvovirus Vaccine Company Information
7.3.2 Zoetis Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.3.3 Zoetis Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Zoetis Main Business and Markets Served
7.3.5 Zoetis Recent Developments/Updates
7.4 Ceva
7.4.1 Ceva Inactivated Porcine Parvovirus Vaccine Company Information
7.4.2 Ceva Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.4.3 Ceva Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Ceva Main Business and Markets Served
7.4.5 Ceva Recent Developments/Updates
7.5 Bioveta
7.5.1 Bioveta Inactivated Porcine Parvovirus Vaccine Company Information
7.5.2 Bioveta Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.5.3 Bioveta Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Bioveta Main Business and Markets Served
7.5.5 Bioveta Recent Developments/Updates
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Company Information
7.6.2 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.6.3 Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Boehringer Ingelheim Main Business and Markets Served
7.6.5 Boehringer Ingelheim Recent Developments/Updates
7.7 Harbin Pharmaceutical Group
7.7.1 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Company Information
7.7.2 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.7.3 Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Harbin Pharmaceutical Group Main Business and Markets Served
7.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
7.8 Wuhan Keqian Biology
7.8.1 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Company Information
7.8.2 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.8.3 Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Wuhan Keqian Biology Main Business and Markets Served
7.8.5 Wuhan Keqian Biology Recent Developments/Updates
7.9 DHN
7.9.1 DHN Inactivated Porcine Parvovirus Vaccine Company Information
7.9.2 DHN Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.9.3 DHN Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.9.4 DHN Main Business and Markets Served
7.9.5 DHN Recent Developments/Updates
7.10 China Animal Husbandy Industry
7.10.1 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Company Information
7.10.2 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.10.3 China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.10.4 China Animal Husbandy Industry Main Business and Markets Served
7.10.5 China Animal Husbandy Industry Recent Developments/Updates
7.11 Qilu Animal Health Products Factorys
7.11.1 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Company Information
7.11.2 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.11.3 Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Qilu Animal Health Products Factorys Main Business and Markets Served
7.11.5 Qilu Animal Health Products Factorys Recent Developments/Updates
7.12 Shandong HuaHong Biological Engineering
7.12.1 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Company Information
7.12.2 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.12.3 Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Shandong HuaHong Biological Engineering Main Business and Markets Served
7.12.5 Shandong HuaHong Biological Engineering Recent Developments/Updates
7.13 Shanghai Hile Biological
7.13.1 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Company Information
7.13.2 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.13.3 Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Shanghai Hile Biological Main Business and Markets Served
7.13.5 Shanghai Hile Biological Recent Developments/Updates
7.14 Liaoning Yikang Biological
7.14.1 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Company Information
7.14.2 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.14.3 Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Liaoning Yikang Biological Main Business and Markets Served
7.14.5 Liaoning Yikang Biological Recent Developments/Updates
7.15 Jilin Zhengye Biological Product
7.15.1 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Company Information
7.15.2 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Product Portfolio
7.15.3 Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Jilin Zhengye Biological Product Main Business and Markets Served
7.15.5 Jilin Zhengye Biological Product Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Inactivated Porcine Parvovirus Vaccine Industry Chain Analysis
8.2 Inactivated Porcine Parvovirus Vaccine Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Inactivated Porcine Parvovirus Vaccine Production Mode & Process Analysis
8.4 Inactivated Porcine Parvovirus Vaccine Sales and Marketing
8.4.1 Inactivated Porcine Parvovirus Vaccine Sales Channels
8.4.2 Inactivated Porcine Parvovirus Vaccine Distributors
8.5 Inactivated Porcine Parvovirus Vaccine Customer Analysis
9 Inactivated Porcine Parvovirus Vaccine Market Dynamics
9.1 Inactivated Porcine Parvovirus Vaccine Industry Trends
9.2 Inactivated Porcine Parvovirus Vaccine Market Drivers
9.3 Inactivated Porcine Parvovirus Vaccine Market Challenges
9.4 Inactivated Porcine Parvovirus Vaccine Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Inactivated Porcine Parvovirus Vaccine Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Inactivated Porcine Parvovirus Vaccine Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) by Manufacturers in 2024
Table 4. Global Inactivated Porcine Parvovirus Vaccine Production by Manufacturers (2020-2025) & (M Doses)
Table 5. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Manufacturers (2020-2025)
Table 6. Global Inactivated Porcine Parvovirus Vaccine Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Inactivated Porcine Parvovirus Vaccine, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Inactivated Porcine Parvovirus Vaccine as of 2024)
Table 10. Global Market Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturers (US$/K Doses) & (2020-2025)
Table 11. Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Product Offered and Application
Table 13. Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Date of Enter into This Industry
Table 14. Global Inactivated Porcine Parvovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Porcine Parvovirus Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2020-2025)
Table 19. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Inactivated Porcine Parvovirus Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 22. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Region (2020-2025)
Table 23. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2020-2025)
Table 24. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) Forecast by Region (2026-2031)
Table 25. Global Inactivated Porcine Parvovirus Vaccine Production Market Share Forecast by Region (2026-2031)
Table 26. Global Inactivated Porcine Parvovirus Vaccine Market Average Price (US$/K Doses) by Region (2020-2025)
Table 27. Global Inactivated Porcine Parvovirus Vaccine Market Average Price (US$/K Doses) by Region (2026-2031)
Table 28. Global Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 29. Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2025) & (M Doses)
Table 30. Global Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region (2020-2025)
Table 31. Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption by Region (2026-2031) & (M Doses)
Table 32. Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 34. North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 35. North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 36. Europe Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 37. Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 38. Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 39. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 40. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2025) & (M Doses)
Table 41. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2026-2031) & (M Doses)
Table 42. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 43. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 44. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 45. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Type (2020-2025)
Table 46. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Type (2026-2031)
Table 47. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2020-2025)
Table 48. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2026-2031)
Table 49. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2020-2025)
Table 52. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2026-2031)
Table 53. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2020-2025)
Table 54. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2026-2031)
Table 55. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Application (2020-2025)
Table 56. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Application (2026-2031)
Table 57. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2020-2025)
Table 58. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2026-2031)
Table 59. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2020-2025)
Table 62. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2026-2031)
Table 63. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2020-2025)
Table 64. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2026-2031)
Table 65. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Company Information
Table 66. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 67. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 68. Merck Animal Health Main Business and Markets Served
Table 69. Merck Animal Health Recent Developments/Updates
Table 70. HIPRA Inactivated Porcine Parvovirus Vaccine Company Information
Table 71. HIPRA Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 72. HIPRA Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 73. HIPRA Main Business and Markets Served
Table 74. HIPRA Recent Developments/Updates
Table 75. Zoetis Inactivated Porcine Parvovirus Vaccine Company Information
Table 76. Zoetis Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 77. Zoetis Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 78. Zoetis Main Business and Markets Served
Table 79. Zoetis Recent Developments/Updates
Table 80. Ceva Inactivated Porcine Parvovirus Vaccine Company Information
Table 81. Ceva Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 82. Ceva Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 83. Ceva Main Business and Markets Served
Table 84. Ceva Recent Developments/Updates
Table 85. Bioveta Inactivated Porcine Parvovirus Vaccine Company Information
Table 86. Bioveta Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 87. Bioveta Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 88. Bioveta Main Business and Markets Served
Table 89. Bioveta Recent Developments/Updates
Table 90. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Company Information
Table 91. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 92. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 93. Boehringer Ingelheim Main Business and Markets Served
Table 94. Boehringer Ingelheim Recent Developments/Updates
Table 95. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Company Information
Table 96. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 97. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 98. Harbin Pharmaceutical Group Main Business and Markets Served
Table 99. Harbin Pharmaceutical Group Recent Developments/Updates
Table 100. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Company Information
Table 101. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 102. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 103. Wuhan Keqian Biology Main Business and Markets Served
Table 104. Wuhan Keqian Biology Recent Developments/Updates
Table 105. DHN Inactivated Porcine Parvovirus Vaccine Company Information
Table 106. DHN Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 107. DHN Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 108. DHN Main Business and Markets Served
Table 109. DHN Recent Developments/Updates
Table 110. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Company Information
Table 111. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 112. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 113. China Animal Husbandy Industry Main Business and Markets Served
Table 114. China Animal Husbandy Industry Recent Developments/Updates
Table 115. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Company Information
Table 116. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 117. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 118. Qilu Animal Health Products Factorys Main Business and Markets Served
Table 119. Qilu Animal Health Products Factorys Recent Developments/Updates
Table 120. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Company Information
Table 121. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 122. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 123. Shandong HuaHong Biological Engineering Main Business and Markets Served
Table 124. Shandong HuaHong Biological Engineering Recent Developments/Updates
Table 125. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Company Information
Table 126. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 127. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 128. Shanghai Hile Biological Main Business and Markets Served
Table 129. Shanghai Hile Biological Recent Developments/Updates
Table 130. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Company Information
Table 131. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 132. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 133. Liaoning Yikang Biological Main Business and Markets Served
Table 134. Liaoning Yikang Biological Recent Developments/Updates
Table 135. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Company Information
Table 136. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 137. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 138. Jilin Zhengye Biological Product Main Business and Markets Served
Table 139. Jilin Zhengye Biological Product Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Inactivated Porcine Parvovirus Vaccine Distributors List
Table 143. Inactivated Porcine Parvovirus Vaccine Customers List
Table 144. Inactivated Porcine Parvovirus Vaccine Market Trends
Table 145. Inactivated Porcine Parvovirus Vaccine Market Drivers
Table 146. Inactivated Porcine Parvovirus Vaccine Market Challenges
Table 147. Inactivated Porcine Parvovirus Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inactivated Porcine Parvovirus Vaccine
Figure 2. Global Inactivated Porcine Parvovirus Vaccine Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Inactivated Porcine Parvovirus Vaccine Market Share by Type: 2024 VS 2031
Figure 4. <107.0 TCID50/mL Product Picture
Figure 5. ≥107.0 TCID50/mL Product Picture
Figure 6. Global Inactivated Porcine Parvovirus Vaccine Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Inactivated Porcine Parvovirus Vaccine Market Share by Application: 2024 VS 2031
Figure 8. Sows
Figure 9. Gilts
Figure 10. Boars
Figure 11. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) & (2020-2031)
Figure 13. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) & (2020-2031)
Figure 14. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) & (2020-2031)
Figure 15. Global Inactivated Porcine Parvovirus Vaccine Average Price (US$/K Doses) & (2020-2031)
Figure 16. Inactivated Porcine Parvovirus Vaccine Report Years Considered
Figure 17. Inactivated Porcine Parvovirus Vaccine Production Share by Manufacturers in 2024
Figure 18. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Manufacturers (2024)
Figure 19. Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. The Global 5 and 10 Largest Players: Market Share by Inactivated Porcine Parvovirus Vaccine Revenue in 2024
Figure 21. Global Inactivated Porcine Parvovirus Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 22. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 23. Global Inactivated Porcine Parvovirus Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 24. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. North America Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. Europe Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. China Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Global Inactivated Porcine Parvovirus Vaccine Consumption by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 30. Global Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 31. North America Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 32. North America Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2020-2031)
Figure 33. U.S. Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 34. Canada Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 35. Europe Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 36. Europe Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2020-2031)
Figure 37. Germany Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 38. France Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 39. U.K. Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 40. Italy Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 41. Russia Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 42. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 43. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region (2020-2031)
Figure 44. China Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 45. Japan Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 46. South Korea Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 47. China Taiwan Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 48. Southeast Asia Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 49. India Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 50. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 51. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2020-2031)
Figure 52. Mexico Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 53. Brazil Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 54. Turkey Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 55. GCC Countries Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 56. Global Production Market Share of Inactivated Porcine Parvovirus Vaccine by Type (2020-2031)
Figure 57. Global Production Value Market Share of Inactivated Porcine Parvovirus Vaccine by Type (2020-2031)
Figure 58. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2020-2031)
Figure 59. Global Production Market Share of Inactivated Porcine Parvovirus Vaccine by Application (2020-2031)
Figure 60. Global Production Value Market Share of Inactivated Porcine Parvovirus Vaccine by Application (2020-2031)
Figure 61. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2020-2031)
Figure 62. Inactivated Porcine Parvovirus Vaccine Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Table 1. Global Inactivated Porcine Parvovirus Vaccine Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Inactivated Porcine Parvovirus Vaccine Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) by Manufacturers in 2024
Table 4. Global Inactivated Porcine Parvovirus Vaccine Production by Manufacturers (2020-2025) & (M Doses)
Table 5. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Manufacturers (2020-2025)
Table 6. Global Inactivated Porcine Parvovirus Vaccine Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Inactivated Porcine Parvovirus Vaccine, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Inactivated Porcine Parvovirus Vaccine as of 2024)
Table 10. Global Market Inactivated Porcine Parvovirus Vaccine Average Price by Manufacturers (US$/K Doses) & (2020-2025)
Table 11. Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Product Offered and Application
Table 13. Global Key Manufacturers of Inactivated Porcine Parvovirus Vaccine, Date of Enter into This Industry
Table 14. Global Inactivated Porcine Parvovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Porcine Parvovirus Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region (2020-2025)
Table 19. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Inactivated Porcine Parvovirus Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 22. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Region (2020-2025)
Table 23. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region (2020-2025)
Table 24. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) Forecast by Region (2026-2031)
Table 25. Global Inactivated Porcine Parvovirus Vaccine Production Market Share Forecast by Region (2026-2031)
Table 26. Global Inactivated Porcine Parvovirus Vaccine Market Average Price (US$/K Doses) by Region (2020-2025)
Table 27. Global Inactivated Porcine Parvovirus Vaccine Market Average Price (US$/K Doses) by Region (2026-2031)
Table 28. Global Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 29. Global Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2025) & (M Doses)
Table 30. Global Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region (2020-2025)
Table 31. Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption by Region (2026-2031) & (M Doses)
Table 32. Global Inactivated Porcine Parvovirus Vaccine Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 34. North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 35. North America Inactivated Porcine Parvovirus Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 36. Europe Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 37. Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 38. Europe Inactivated Porcine Parvovirus Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 39. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 40. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2020-2025) & (M Doses)
Table 41. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption by Region (2026-2031) & (M Doses)
Table 42. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Doses)
Table 43. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2020-2025) & (M Doses)
Table 44. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption by Country (2026-2031) & (M Doses)
Table 45. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Type (2020-2025)
Table 46. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Type (2026-2031)
Table 47. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2020-2025)
Table 48. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Type (2026-2031)
Table 49. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2020-2025)
Table 52. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Type (2026-2031)
Table 53. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2020-2025)
Table 54. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2026-2031)
Table 55. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Application (2020-2025)
Table 56. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) by Application (2026-2031)
Table 57. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2020-2025)
Table 58. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Application (2026-2031)
Table 59. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2020-2025)
Table 62. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Application (2026-2031)
Table 63. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2020-2025)
Table 64. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2026-2031)
Table 65. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Company Information
Table 66. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 67. Merck Animal Health Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 68. Merck Animal Health Main Business and Markets Served
Table 69. Merck Animal Health Recent Developments/Updates
Table 70. HIPRA Inactivated Porcine Parvovirus Vaccine Company Information
Table 71. HIPRA Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 72. HIPRA Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 73. HIPRA Main Business and Markets Served
Table 74. HIPRA Recent Developments/Updates
Table 75. Zoetis Inactivated Porcine Parvovirus Vaccine Company Information
Table 76. Zoetis Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 77. Zoetis Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 78. Zoetis Main Business and Markets Served
Table 79. Zoetis Recent Developments/Updates
Table 80. Ceva Inactivated Porcine Parvovirus Vaccine Company Information
Table 81. Ceva Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 82. Ceva Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 83. Ceva Main Business and Markets Served
Table 84. Ceva Recent Developments/Updates
Table 85. Bioveta Inactivated Porcine Parvovirus Vaccine Company Information
Table 86. Bioveta Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 87. Bioveta Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 88. Bioveta Main Business and Markets Served
Table 89. Bioveta Recent Developments/Updates
Table 90. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Company Information
Table 91. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 92. Boehringer Ingelheim Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 93. Boehringer Ingelheim Main Business and Markets Served
Table 94. Boehringer Ingelheim Recent Developments/Updates
Table 95. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Company Information
Table 96. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 97. Harbin Pharmaceutical Group Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 98. Harbin Pharmaceutical Group Main Business and Markets Served
Table 99. Harbin Pharmaceutical Group Recent Developments/Updates
Table 100. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Company Information
Table 101. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 102. Wuhan Keqian Biology Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 103. Wuhan Keqian Biology Main Business and Markets Served
Table 104. Wuhan Keqian Biology Recent Developments/Updates
Table 105. DHN Inactivated Porcine Parvovirus Vaccine Company Information
Table 106. DHN Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 107. DHN Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 108. DHN Main Business and Markets Served
Table 109. DHN Recent Developments/Updates
Table 110. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Company Information
Table 111. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 112. China Animal Husbandy Industry Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 113. China Animal Husbandy Industry Main Business and Markets Served
Table 114. China Animal Husbandy Industry Recent Developments/Updates
Table 115. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Company Information
Table 116. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 117. Qilu Animal Health Products Factorys Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 118. Qilu Animal Health Products Factorys Main Business and Markets Served
Table 119. Qilu Animal Health Products Factorys Recent Developments/Updates
Table 120. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Company Information
Table 121. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 122. Shandong HuaHong Biological Engineering Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 123. Shandong HuaHong Biological Engineering Main Business and Markets Served
Table 124. Shandong HuaHong Biological Engineering Recent Developments/Updates
Table 125. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Company Information
Table 126. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 127. Shanghai Hile Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 128. Shanghai Hile Biological Main Business and Markets Served
Table 129. Shanghai Hile Biological Recent Developments/Updates
Table 130. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Company Information
Table 131. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 132. Liaoning Yikang Biological Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 133. Liaoning Yikang Biological Main Business and Markets Served
Table 134. Liaoning Yikang Biological Recent Developments/Updates
Table 135. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Company Information
Table 136. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Specification and Application
Table 137. Jilin Zhengye Biological Product Inactivated Porcine Parvovirus Vaccine Production (M Doses), Value (US$ Million), Price (US$/K Doses) and Gross Margin (2020-2025)
Table 138. Jilin Zhengye Biological Product Main Business and Markets Served
Table 139. Jilin Zhengye Biological Product Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Inactivated Porcine Parvovirus Vaccine Distributors List
Table 143. Inactivated Porcine Parvovirus Vaccine Customers List
Table 144. Inactivated Porcine Parvovirus Vaccine Market Trends
Table 145. Inactivated Porcine Parvovirus Vaccine Market Drivers
Table 146. Inactivated Porcine Parvovirus Vaccine Market Challenges
Table 147. Inactivated Porcine Parvovirus Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inactivated Porcine Parvovirus Vaccine
Figure 2. Global Inactivated Porcine Parvovirus Vaccine Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Inactivated Porcine Parvovirus Vaccine Market Share by Type: 2024 VS 2031
Figure 4. <107.0 TCID50/mL Product Picture
Figure 5. ≥107.0 TCID50/mL Product Picture
Figure 6. Global Inactivated Porcine Parvovirus Vaccine Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Inactivated Porcine Parvovirus Vaccine Market Share by Application: 2024 VS 2031
Figure 8. Sows
Figure 9. Gilts
Figure 10. Boars
Figure 11. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) & (2020-2031)
Figure 13. Global Inactivated Porcine Parvovirus Vaccine Production Capacity (M Doses) & (2020-2031)
Figure 14. Global Inactivated Porcine Parvovirus Vaccine Production (M Doses) & (2020-2031)
Figure 15. Global Inactivated Porcine Parvovirus Vaccine Average Price (US$/K Doses) & (2020-2031)
Figure 16. Inactivated Porcine Parvovirus Vaccine Report Years Considered
Figure 17. Inactivated Porcine Parvovirus Vaccine Production Share by Manufacturers in 2024
Figure 18. Global Inactivated Porcine Parvovirus Vaccine Production Value Share by Manufacturers (2024)
Figure 19. Inactivated Porcine Parvovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. The Global 5 and 10 Largest Players: Market Share by Inactivated Porcine Parvovirus Vaccine Revenue in 2024
Figure 21. Global Inactivated Porcine Parvovirus Vaccine Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 22. Global Inactivated Porcine Parvovirus Vaccine Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 23. Global Inactivated Porcine Parvovirus Vaccine Production Comparison by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 24. Global Inactivated Porcine Parvovirus Vaccine Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. North America Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. Europe Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. China Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Inactivated Porcine Parvovirus Vaccine Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Global Inactivated Porcine Parvovirus Vaccine Consumption by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 30. Global Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 31. North America Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 32. North America Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2020-2031)
Figure 33. U.S. Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 34. Canada Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 35. Europe Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 36. Europe Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2020-2031)
Figure 37. Germany Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 38. France Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 39. U.K. Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 40. Italy Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 41. Russia Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 42. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 43. Asia Pacific Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Region (2020-2031)
Figure 44. China Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 45. Japan Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 46. South Korea Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 47. China Taiwan Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 48. Southeast Asia Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 49. India Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 50. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 51. Latin America, Middle East & Africa Inactivated Porcine Parvovirus Vaccine Consumption Market Share by Country (2020-2031)
Figure 52. Mexico Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 53. Brazil Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 54. Turkey Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 55. GCC Countries Inactivated Porcine Parvovirus Vaccine Consumption and Growth Rate (2020-2031) & (M Doses)
Figure 56. Global Production Market Share of Inactivated Porcine Parvovirus Vaccine by Type (2020-2031)
Figure 57. Global Production Value Market Share of Inactivated Porcine Parvovirus Vaccine by Type (2020-2031)
Figure 58. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Type (2020-2031)
Figure 59. Global Production Market Share of Inactivated Porcine Parvovirus Vaccine by Application (2020-2031)
Figure 60. Global Production Value Market Share of Inactivated Porcine Parvovirus Vaccine by Application (2020-2031)
Figure 61. Global Inactivated Porcine Parvovirus Vaccine Price (US$/K Doses) by Application (2020-2031)
Figure 62. Inactivated Porcine Parvovirus Vaccine Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oil in Water Monitoring Sensor Market Research Report 2025
Jun 06, 25
Global Large LCD Display Market Research Report 2025
Jun 06, 25
Global Commercial LCD Monitor Market Research Report 2025
Jun 06, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232